Logo image of CPHI

CHINA PHARMA HOLDINGS INC (CPHI) Stock Price, Forecast & Analysis

USA - NYSEARCA:CPHI - US16941T4013 - Common Stock

1.64 USD
-0.09 (-5.2%)
Last: 10/31/2025, 8:04:03 PM

CPHI Key Statistics, Chart & Performance

Key Statistics
Market Cap5.35M
Revenue(TTM)4.40M
Net Income(TTM)-3656300
Shares3.26M
Float2.64M
52 Week High3.35
52 Week Low1.2
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.58
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2000-02-15
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CPHI short term performance overview.The bars show the price performance of CPHI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10

CPHI long term performance overview.The bars show the price performance of CPHI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CPHI is 1.64 USD. In the past month the price decreased by -13.23%. In the past year, price decreased by -36.06%.

CHINA PHARMA HOLDINGS INC / CPHI Daily stock chart

CPHI Latest News, Press Relases and Analysis

CPHI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 39.24 816.66B
JNJ JOHNSON & JOHNSON 18.2 454.86B
AZN ASTRAZENECA PLC-SPONS ADR 18.56 255.48B
NVS NOVARTIS AG-SPONSORED ADR 13.83 239.64B
NVO NOVO-NORDISK A/S-SPONS ADR 12.81 219.77B
MRK MERCK & CO. INC. 9.87 214.76B
PFE PFIZER INC 7.27 140.15B
SNY SANOFI-ADR 11.52 123.27B
GSK GSK PLC-SPON ADR 7.73 94.25B
BMY BRISTOL-MYERS SQUIBB CO 7.02 93.77B
ZTS ZOETIS INC 23.17 63.86B
TAK TAKEDA PHARMACEUTIC-SP ADR 48 42.45B

About CPHI

Company Profile

CPHI logo image China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Company Info

CHINA PHARMA HOLDINGS INC

2nd Floor, No. 17, Jinpan Road, Haikou

Haikou HAINAN 570216 CN

CEO: Zhilin Li

Employees: 224

CPHI Company Website

CPHI Investor Relations

Phone: 8689866811730

CHINA PHARMA HOLDINGS INC / CPHI FAQ

Can you describe the business of CHINA PHARMA HOLDINGS INC?

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.


What is the current price of CPHI stock?

The current stock price of CPHI is 1.64 USD. The price decreased by -5.2% in the last trading session.


Does CPHI stock pay dividends?

CPHI does not pay a dividend.


What is the ChartMill technical and fundamental rating of CPHI stock?

CPHI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the number of employees for CHINA PHARMA HOLDINGS INC?

CHINA PHARMA HOLDINGS INC (CPHI) currently has 224 employees.


CPHI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CPHI. When comparing the yearly performance of all stocks, CPHI is a bad performer in the overall market: 87.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CPHI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to CPHI. CPHI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CPHI Financial Highlights

Over the last trailing twelve months CPHI reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS increased by 74.7% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.56%
ROE -56.58%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%81.84%
Sales Q2Q%10.91%
EPS 1Y (TTM)74.7%
Revenue 1Y (TTM)-29.64%

CPHI Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

CPHI Ownership

Ownership
Inst Owners3.64%
Ins Owners19.05%
Short Float %0.15%
Short Ratio0.13